Optical technologies are attractive for clinical translation because these techniques are inexpensive, portable, fast and provide a wealth of information on tissue structure and function. We are particularly interested in developing personalized cancer treatment strategies, and in developing more effective cancer therapies. Technology development focuses on metabolic and functional imaging of the tumor and its microenvironment (e.g. metabolic activity, blood vessel morphology, blood oxygenation, blood flow, and molecular expression).

Principal Investigator Melissa Skala

Melissa Skala received her BS in Physics at Washington State University in 2002, her M.S. in Biomedical Engineering at the University of Wisconsin, Madison in 2004, and her Ph.D. in Biomedical Engineering at Duke University in 2007. Her postdoctoral training was also in Biomedical Engineering at Duke University, from 2007-2010. From 2010-2016, she was an Assistant Professor of Biomedical Engineering at Vanderbilt University. Since 2016 she has been an Investigator at the Morgridge Institute for Research, and an Associate Professor of Biomedical Engineering at the University of Wisconsin – Madison.

Learn more >